| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.05 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.05 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |